THE COST-EFFECTIVENESS OF CANAGLIFLOZIN COMPARED WITH LIRAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN AND SULFONYLUREA IN FRANCE

被引：1
|
作者：
Troelsgaard, A. [1 ]
Pitcher, A. [2 ]
Granados, D. [3 ]
Hemels, M. [1 ]
Lloyd, A. [2 ]
机构：
[1] Janssen AS, Birkerod, Denmark
[2] IMS Hlth, London, England
[3] Janssen, Paris, France
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.707
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB85
引用
收藏
页码：A346 / A347
页数：2
相关论文
共 50 条
  • [1] THE COST-EFFECTIVENESS EVALUATION OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN MONOTHERAPY IN SPAIN
    Nielsen, A. T.
    Pitcher, A.
    Lovato, E.
    Schubert, A.
    Hemels, M.
    Neslusan, C.
    Gonzalez, B.
    VALUE IN HEALTH, 2015, 18 (03) : A61 - A61
  • [2] Cost-effectiveness of adding sitagliptin vs. an sulfonylurea in Swiss patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Brandle, M.
    Chen, J.
    Alemao, E.
    Yin, D.
    Cook, J.
    Szucs, T.
    DIABETOLOGIA, 2008, 51 : S446 - S446
  • [3] COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA
    Sabapathy, Suthakar
    Neslusan, Cheryl
    Yoong, Kim
    Teschemaker, Anna
    Johansen, Pierre
    Willis, Michael
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2016, 23 (02): : E151 - E168
  • [4] Cost-effectiveness of dapagliflozin (Forxiga®) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countries
    Sabale, Ugne
    Ekman, Mattias
    Granstrom, Ola
    Bergenheim, Klas
    McEwan, Phil
    PRIMARY CARE DIABETES, 2015, 9 (01) : 39 - 47
  • [5] Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China
    Hou, Xingyun
    Wan, Xu
    Wu, Bin
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [6] COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Hou, X.
    Wan, X.
    Li, Y.
    Ding, Y.
    Wu, B.
    VALUE IN HEALTH, 2019, 22 : S144 - S144
  • [7] Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
    Klarenbach, Scott
    Cameron, Chris
    Singh, Sumeet
    Ur, Ehud
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (16) : E1213 - E1220
  • [8] Lifetime Cost-effectiveness of Oral Semaglutide Versus Dulaglutide and Liraglutide in Patients With Type 2 Diabetes Inadequately Controlled With Oral Antidiabetics
    Risebrough, Nancy A.
    Baker, Timothy M.
    Zhang, Lirong
    Ali, Sarah N.
    Radin, Michael
    Dang-Tan, Tam
    CLINICAL THERAPEUTICS, 2021, 43 (11) : 1812 - +
  • [9] COST-EFFECTIVENESS ANALYSIS OF LIRAGLUTIDE VERSUS INSULIN GLARGINE IN CHINESE PATIENTS WITH TYPE 2 DIABETES INSUFFICIENTLY CONTROLLED ON METFORMIN
    Gu, X.
    Liu, F.
    Men, P.
    Zhai, S.
    VALUE IN HEALTH, 2018, 21 : S75 - S75
  • [10] Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece
    Tzanetakos, Charalampos
    Melidonis, Andreas
    Verras, Christos
    Kourlaba, Georgia
    Maniadakis, Nikos
    BMC HEALTH SERVICES RESEARCH, 2014, 14
12345